PGTA (Preimplantation Genetic Testing for Aneuploidies) is an advanced genetic screening technique performed during IVF to check embryos for chromosomal abnormalities. Aneuploidies occur when an embryo has too many or too few chromosomes, which can lead to failed implantation, miscarriage, or genetic conditions such as Down syndrome. PGTA ensures only chromosomally normal embryos are selected for transfer, improving the chances of a healthy pregnancy.
PGTA uses cutting-edge techniques like Next-Generation Sequencing (NGS), Comparative Genomic Hybridization (CGH), and microarray analysis to accurately detect aneuploidies. This ensures the transfer of only the healthiest embryos, leading to higher success rates and improved pregnancy outcomes.